AHFS Drug Information 5.1.1

Try before you buy - Download the FREE App, which includes sample content. An in-App purchase is required to unlock all content.

AHFS Drug Information® 2024: AHFS® Drug Information™ - Doody's Core Title - is a comprehensive, interactive treatment and drug therapy solution featuring therapeutic guidelines and off-label uses.

This publication was honored as a Doody's Core Title in 2023. AHFS Drug Information® 2024 provides a centralized, evidence-based source of drug information including therapeutic guidelines and off-label uses. Featuring expanded and revised content supported by over 97,000 references and insights from numerous subject matter experts, AHFS DI aims to assist healthcare professionals in safeguarding their patients and practice.

• Clinical perspective sections offering place of therapy discussions and recommendations from therapeutic guidelines
• Expanded coverage of specialty medications used for complex, chronic conditions
• Updated content on contemporary topics such as new treatments and vaccines
• Enhanced information on new and emerging gene therapies
• Various vaccine monographs updates including safety alerts, FDA updates, and more
• Searchable database with user-specific favorites and notes creation options
• AHFS class for each drug based on the AHFS® Pharmacologic-Therapeutic Classification

The content is licensed from printed ISBN 10: 1585287210 and printed ISBN 13: 9781585287215.

SUBSCRIPTION:
Please purchase a yearly auto-renewing subscription to access the complete content and receive updates.
Yearly auto-renewing subscription: $99.99
Payment charged to your iTunes Account upon confirmation of purchase. Subscription auto-renews unless disabled at least 24-hours before the current period ends.

Contact us via email at customersupport@skyscape.com or call 508-299-3000 for any inquiries.

For more information, refer to our:
Privacy Policy - Privacy Policy
Terms and Conditions - Terms and Conditions